North America Dna Microarray Market Size & Outlook
North America dna microarray market, 2018-2030 (US$M)
Related Markets
North America dna microarray market highlights
- The North America dna microarray market generated a revenue of USD 894.3 million in 2022.
- The market is expected to grow at a CAGR of 8% from 2023 to 2030.
- In terms of segment, oligonucleotide dna microarrays was the largest revenue generating type in 2022.
- Complementary DNA Microarrays is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 894.3 million |
| Market revenue in 2030 | USD 1,655.9 million |
| Growth rate | 8% (CAGR from 2022 to 2030) |
| Largest segment | Oligonucleotide dna microarrays |
| Fastest growing segment | Complementary DNA Microarrays |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complementary DNA Microarrays, Oligonucleotide DNA Microarrays |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG, Agilent Technologies, Merck KGaA, BioMerieux SA, PerkinElmer, Advanced Micro Devices Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 48.7% of the global dna microarray market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 687.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Microarray Market Scope
DNA Microarray Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America dna microarray market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna microarray market will help companies and investors design strategic landscapes.
Oligonucleotide dna microarrays was the largest segment with a revenue share of 72.16% in 2022. Horizon Databook has segmented the North America dna microarray market based on complementary dna microarrays, oligonucleotide dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
- North America DNA Microarray Type Outlook (Revenue, USD Million, 2018-2030)
- Complementary DNA Microarrays
- Oligonucleotide DNA Microarrays
- Others
- North America DNA Microarray Application Outlook (Revenue, USD Million, 2018-2030)
- Gene Expression Analysis
- Genotyping
- Others
- North America DNA Microarray End-user Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical and Biotechnology Companies
- Diagnostic Centers
- Hospitals and Clinics
- Academic and Research Institute
- Others
Reasons to subscribe to North America dna microarray market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America dna microarray market databook
-
Our clientele includes a mix of dna microarray market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America dna microarray market, including forecasts for subscribers. This continent databook contains high-level insights into North America dna microarray market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America dna microarray market report size, by country, 2018-2030 (US$M)
North America DNA Microarray Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
